ABT — ABBOTT LABORATORIES
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1800 ·
Last close
$104.71
Market Cap
$181.35B
52W High
$128.83
52W Low
$80.89
ADV30
9,308,737
Next earnings
2027-01-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 11,164,000,000 | 6,274,000,000 | 1,345,000,000 | 1,077,000,000 | 110,429,000,000 | 6,803,000,000 | 57,728,000,000 |
| Dec 2025 | 11,459,000,000 | 6,537,000,000 | 2,251,000,000 | 1,776,000,000 | 86,713,000,000 | 8,522,000,000 | 33,942,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$9,154,000,000
Investing CF
$-22,079,000,000
Financing CF
$11,751,000,000
CapEx
$-2,097,000,000
Dividends Paid
$-4,253,000,000
Buybacks
$-798,000,000
EPS Diluted TTM
$2.68
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$49,638,000,000
Inventory
$7,337,000,000
Receivables
$11,861,000,000
ST Investments
$246,000,000
EBIT TTM
$7,983,000,000
Pretax Income TTM
$7,218,000,000
Interest Exp TTM
$765,000,000
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$48,228,999,168
EBITDA
$11,457,999,872
Free Cash Flow
$6,066,999,808
Enterprise Value
$218,128,334,848
Total Cash
$4,297,999,872
Total Debt
$31,438,000,128
Shares Out
1,731,941,601
Trailing EPS
$2.68
Book Value
$29.46
ROE
9.1%
ROA
4.9%
Div Yield
2.29%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,328,000,000 | 8,053,000,000 | 6,524,000,000 | 86,713,000,000 | 33,942,000,000 | 52,130,000,000 | 9,566,000,000 |
| Dec 2024 | 41,950,000,000 | 6,825,000,000 | 13,402,000,000 | 81,414,000,000 | 33,513,000,000 | 47,664,000,000 | 8,558,000,000 |
| Dec 2023 | 40,109,000,000 | 6,478,000,000 | 5,723,000,000 | 73,214,000,000 | 34,387,000,000 | 38,603,000,000 | 7,261,000,000 |
| Dec 2022 | 43,653,000,000 | 8,362,000,000 | 6,933,000,000 | 74,438,000,000 | 37,533,000,000 | 36,686,000,000 | 9,581,000,000 |
TTM Snapshot
Revenues TTM
$46,585,000,000
NetIncome TTM
$5,425,000,000
OpCashFlow TTM
—
Assets (Latest)
$109,215,000,000
Forward EPS
$5.94
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $100.00 · spot: $104.48 · call volume: 1,002 · put volume: 1,192
Expected Move to 2027-01-15:
±$9.10
(8.71%) —
implied range
$95.38 –
$113.58
· ATM straddle on $105.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PFE | PFIZER INC | $162.27B | $28.47 | — |
| NVO | NOVO NORDISK A S | $136.10B | $40.70 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $135.44B | $534.20 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $125.40B | $61.35 | — |
| AZN | ASTRAZENECA PLC | $282.68B | $182.27 | — |
News headlines (Yahoo Finance, 1h cache)
Abbott (ABT) Stock May Be 28% Undervalued Despite AI Testing Expansion
2026-11-17 18:08 · Yahoo
Non-Animal Alternative Testing - Global Strategic Business Report 2026: Capitalize on 13.3% CAGR and $4.7B by 2032 as Abbott, Charles River, Emulate, Evotec, and Bio-Rad Reshape Testing
2026-11-16 15:45 · Yahoo
Global Point of Care (POC) Immunoassay Analyzer Expansion Market 2026 | Capture 8.8% CAGR to 2030 as Roche, Abbott, Siemens Healthineers and Danaher Scale AI-Enabled POC Testing
2026-11-16 15:27 · Yahoo
Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026
2026-11-16 11:50 · Yahoo
Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?
2026-11-13 15:15 · Yahoo
Microfluidic Device Systems - Global Strategic Business Report 2026: Capitalize on 8.7% CAGR to $11.1 Billion by 2032 | Abbott, Danaher, Bio-Rad, and Siemens Healthineers Shape the Competition
2026-11-12 14:57 · Yahoo
Is Abbott Laboratories (ABT) Undervalued On New Device And Test Launches?
2026-11-12 14:10 · Yahoo
Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
2026-11-12 13:30 · Yahoo
Abbott vs. Medtronic: Which Dividend Stock Pays You More in 10 Years?
2026-11-12 12:56 · Yahoo
Warren Buffett Says His Favorite Holding Period Is Forever. A Secretary Who Paid $180 for 3 Shares in 1935 and Never Sold Died Worth $7 Million. Here’s What Her Rule Does for $600,000 in One Stock Tod
2026-11-12 03:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.